Bristol Myers Squibb Announces Dividend

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par value common stock of the company.

The dividend is payable on August 3, 2026, to stockholders of record at the close of business on July 2, 2026.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information about Bristol Myers Squibb, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20260617686605/en/

Media Relations:
[email protected]

Investor Relations:
[email protected]

Source: Bristol Myers Squibb

You May Also Be Interested In

• FPT and NAVER Cloud Form Strategic Alliance to Fuel AI Innovation Across Asia-Pacific and Beyond
• Dogecoin Price Prediction: Whales Move $949 Million of DOGE in a Day as Buyers Bet on Pepeto
• Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases